Showing results (31-40 of 71) with videos related to
Sort By:
Pageof 8
Journal of Cellular Physiology|March 28, 2019
Comprehensive analysis of a ceRNA network reveals potential prognostic cytoplasmic lncRNAs involved in HCC progressionYi Bai, Junyu Long, Zhisong Liu, et al.Cancer Management and Research|October 6, 2018
Metabolic syndrome and the risk of cholangiocarcinoma: a hospital-based case-control study in ChinaJianping Xiong, Xin Lu, Weiyu Xu, et al.Annals of Translational Medicine|August 29, 2022
Differentially expressed liver exosome-related genes as candidate prognostic biomarkers for hepatocellular carcinomaBangyou Zuo, Jing Kuai, Junyu Long, et al.BMC Medicine|July 21, 2021
Identification of NOTCH4 mutation as a response biomarker for immune checkpoint inhibitor therapyJunyu Long, Dongxu Wang, Xu Yang, et al.Oncotarget|September 24, 2017
Systematic review and meta-analysis: cholecystectomy and the risk of cholangiocarcinomaJianping Xiong, Yaqin Wang, Hanchun Huang, et al.Frontiers in Cell and Developmental Biology|August 1, 2022
Identification of an m6A-Related Long Noncoding RNA Risk Model for Predicting Prognosis and Directing Treatments in Patients With Colon AdenocarcinomaWanying Liao, Junyu Long, Yiran Li, et al.BMC Cancer|July 30, 2018
Classification of gallbladder cancer by assessment of CD8+ TIL and PD-L1 expressionJianzhen Lin, Junyu Long, Xueshuai Wan, et al.Genome Medicine|February 24, 2022
A mutation-based gene set predicts survival benefit after immunotherapy across multiple cancers and reveals the immune response landscapeJunyu Long, Dongxu Wang, Anqiang Wang, et al.Theranostics|November 8, 2019
DNA methylation-driven genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinomaJunyu Long, Peipei Chen, Jianzhen Lin, et al.Cellular Oncology (Dordrecht, Netherlands)|July 11, 2023
Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic cancerGuangyu Chen, Yueze Liu, Dan Su, et al.Pageof 8